Corestreet Logo

Enliven Therapeutics Inc. (ELVN) Insider Trading

Total insider buys:
  • $0.00
Total insider sells:
  • $57,140,527.10
Most recent insider trade:
  • April 7, 2025
Most active insider trader:
  • Benjamin Hohl
Trader NameDateTitleAmountPriceTypeTotal Value
July 12, 2024COO17,475$25.07Sell$438,098.25
July 12, 2024CFO3,000$25.07Sell$75,210.00
June 27, 2024CFO4,250$22.57Sell$95,922.50
June 25, 2024CEO12,000$21.66Sell$259,920.00
June 6, 2024COO1,133$20.06Sell$22,727.98
May 28, 2024CEO12,000$23.18Sell$278,160.00
May 28, 2024CFO4,250$23.18Sell$98,515.00
May 16, 2024Director1,033,300$22.14Sell$22,877,262.00
May 14, 2024COO1,107$25.00Sell$27,675.00
May 9, 2024COO260$25.06Sell$6,515.60
May 6, 2024COO4,875$22.72Sell$110,760.00
May 3, 2024CFO1,000$22.50Sell$22,500.00
April 29, 2024CFO3,250$16.97Sell$55,152.50
April 29, 2024insider12,000$17.92Sell$215,040.00
April 25, 2024CEO12,000$16.89Sell$202,680.00
April 15, 2024Director1,270$19.99Sell$25,387.30
April 11, 2024COO17,500$25.03Sell$438,025.00
April 11, 2024CFO14,000$24.72Sell$346,080.00
April 11, 2024insider30,000$25.04Sell$751,200.00
April 11, 2024CEO47,709$25.04Sell$1,194,633.36
April 11, 2024Director53,400$23.95Sell$1,278,930.00
April 8, 2024COO4,875$18.60Sell$90,675.00
April 4, 2024Director3,485$19.15Sell$66,737.75
April 1, 2024insider12,000$18.60Sell$223,200.00
April 1, 2024Director3,237$19.08Sell$61,761.96
March 27, 2024CFO3,250$18.25Sell$59,312.50
March 25, 2024CEO12,000$17.56Sell$210,720.00
March 19, 2024Director1,270$14.50Sell$18,415.00
March 6, 2024COO4,875$15.64Sell$76,245.00
Feb. 29, 2024insider12,000$16.42Sell$197,040.00
Feb. 27, 2024CFO3,250$16.97Sell$55,152.50
Feb. 15, 2024Director1,270$17.42Sell$22,123.40
Feb. 6, 2024COO4,875$15.11Sell$73,661.25
Jan. 31, 2024Major Shareholder500,000$15.00Sell$7,500,000.00
Jan. 30, 2024Director1,270$16.41Sell$20,840.70
Jan. 29, 2024insider12,000$15.85Sell$190,200.00
Jan. 29, 2024CFO3,250$15.81Sell$51,382.50
Jan. 25, 2024CEO12,000$15.69Sell$188,280.00
Jan. 22, 2024COO4,875$15.13Sell$73,758.75
Jan. 2, 2024CFO9,383$15.01Sell$140,838.83
Jan. 2, 2024COO11,000$15.00Sell$165,000.00
Dec. 26, 2023CEO12,000$14.64Sell$175,680.00
Dec. 26, 2023CFO100$15.00Sell$1,500.00
Dec. 26, 2023COO102$15.01Sell$1,531.02
Dec. 22, 2023CEO8,175$13.05Sell$106,683.75
Dec. 22, 2023COO983$15.03Sell$14,774.49
Dec. 22, 2023CFO1,030$15.07Sell$15,522.10
Dec. 21, 2023insider20$13.00Sell$260.00
Dec. 21, 2023Director7$13.00Sell$91.00
Dec. 20, 2023CEO7,779$13.01Sell$101,204.79
First«2 of 3»Last

  • Insiders are selling Enliven Therapeutics Inc. stock.

  • The insider traders at Enliven Therapeutics Inc. are: Benjamin Hohl, Samuel Kintz, Anish Patel, Richard A Heyman, Joseph P. Lyssikatos, Joseph P Lyssikatos, Rahul D Ballal, 5Am Partners Vi, Llc, and Rishi Gupta

  • The most active insider trader at Enliven Therapeutics Inc. is Benjamin Hohl with 30 trades.

  • Rishi Gupta has sold the most Enliven Therapeutics Inc. stock with a total value of $45,754,524.00.

  • The most recent insider trade for Enliven Therapeutics Inc. was on April 7, 2025.

  • The single biggest insider sell for Enliven Therapeutics Inc. was from Rishi Gupta with a total value of $22,877,262.00 on May 16, 2024.